The Treatment of Antisocial Personality Disorder

被引:0
|
作者
Black D.W. [1 ]
机构
[1] Department of Psychiatry, University of Iowa Carver College of Medicine, 2-126b MEB/Psychiatry Research, Iowa City, 52242, IA
关键词
Antidepressants; Antipsychotics; Antisocial personality disorder; Cognitive-behavioral therapy; Mood stabilizers; Sociopathy;
D O I
10.1007/s40501-017-0123-z
中图分类号
学科分类号
摘要
Purpose of Review Antisocial personality disorder (ASPD) is defined by its pattern of socially irresponsible, exploitative, and guiltless behavior. The disorder is common and costly to society. ASPD starts in childhood or early adolescence when it is diagnosed as conduct disorder. If the symptoms persist past age 18, the diagnosis changes to ASPD. The disorder moderates with advancing age and many individuals will no longer meet criteria for the disorder as older adults. Recent Findings The treatment of ASPD is challenging and complicated by a dearth of research evidence. There are no medications approved by the US Food and Drug Administration for treatment of the disorder, nor are there proven psychological treatments. Medications can be prescribed to treat comorbid disorders (e.g., panic disorder, major depression), or “off-label” to target aggression and impulsivity associated with ASPD. Treatment models employing cognitive-behavioral therapy have been developed, and some reports suggest benefit. Summary Patients with ASPD should not routinely be treated with psychotropic medication. Medications may be helpful in treating comorbid psychiatric disorders such as major depression, or aggressive symptoms common in these patients. Cognitive-behavior therapy may be helpful for those with milder syndromes. © 2017, Springer International Publishing AG.
引用
收藏
页码:295 / 302
页数:7
相关论文
共 50 条
  • [1] On the coming of age of antisocial personality disorder: A commentary on the NICE treatment guidelines for antisocial personality disorder
    Trestman, Robert L.
    Lazrove, Steven
    [J]. PERSONALITY AND MENTAL HEALTH, 2010, 4 (01) : 12 - 15
  • [2] TREATMENT OUTLINES FOR ANTISOCIAL PERSONALITY-DISORDER
    ANDREWS, G
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1991, 25 (04): : 541 - 547
  • [3] Antisocial personality disorder and TC treatment outcomes
    Messina, NP
    Wish, ED
    Hoffman, JA
    Nemes, S
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2002, 28 (02): : 197 - 212
  • [4] Antisocial personality disorder
    von Nettelbladt, Frederic
    [J]. PSYCHOTHERAPEUT, 2019, 64 (03): : 241 - 258
  • [5] Response to NICE: Guidelines for the treatment of antisocial personality disorder
    Black, Donald W.
    Blum, Nancee
    [J]. PERSONALITY AND MENTAL HEALTH, 2010, 4 (01) : 9 - 11
  • [6] Treatment of antisocial personality disorder: state-of-the-art.
    Fillieux, T
    Godfroid, IO
    [J]. ANNALES MEDICO-PSYCHOLOGIQUES, 2001, 159 (04): : 285 - 293
  • [7] Antisocial Personality Disorder and Opioid Treatment Outcomes: A Review
    Havens, Jennifer R.
    Strathdee, Steffanie A.
    [J]. ADDICTIVE DISORDERS & THEIR TREATMENT, 2005, 4 (03): : 85 - 97
  • [8] The neurobiology of antisocial personality disorder: The quest for rehabilitation and treatment
    Pemment, Jack
    [J]. AGGRESSION AND VIOLENT BEHAVIOR, 2013, 18 (01) : 79 - 82
  • [9] TREATMENT OF ANTISOCIAL PERSONALITY DISORDER AND PSYCHOPATHY: HOPEFUL OR HOPELESS?
    Scott, Charles
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (S1): : 2 - 2
  • [10] Oxcarbazepine in the treatment of severe borderline and antisocial personality disorder
    Mikirditsian, O.
    Istikoglou, C.
    Michelidakis, K.
    Vlissides, D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 202 - 202